As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pfizer: CTC LLC, Barclays PLC, National Bank of Canada FI, Jane Street Group LLC, Wolverine Trading LLC, Symmetry Peak Management LLC, Readystate Asset Management LP, Point72 DIFC Ltd, Parallax Volatility Advisers L.P., Centiva Capital LP, Paloma Partners Management Co, Verition Fund Management LLC, Capstone Investment Advisors LLC, Walleye Trading LLC, Walleye Capital LLC, Crawford Fund Management LLC, PEAK6 Investments LLC, BNP Paribas Financial Markets, Bank of Montreal Can, Citigroup Inc., LPL Financial LLC, LMR Partners LLP, Marathon Trading Investment Management LLC, Jag Capital Management LLC, Wolverine Asset Management LLC, XR Securities LLC, Clear Harbor Asset Management LLC, Concourse Financial Group Securities Inc., Oak Hill Wealth Advisors LLC, and SG Americas Securities LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.